Aro Biotherapeutics

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$41.5M

Aro Biotherapeutics is a clinical stage biotech company specializing in the development of tissue-targeted genetic medicines, including a potential treatment for Pompe Disease and new therapies for autoimmune disorders, using their proprietary Centyrin-siRNA platform.